What legal frameworks govern cross-border carry allocations in VC funds?

Cross-border venture capital carry allocations are governed by an overlapping set of tax, corporate, securities, and international treaty rules that determine how carried interest is characterized, allocated, and taxed across jurisdictions. Practitioners must reconcile partnership agreements and local law with bilateral tax treaties and multilateral anti-abuse initiatives to avoid double taxation, unintended withholding, or recharacterization.

Tax and treaty frameworks

At the core are domestic tax codes and partnership rules such as Section 704 of the Internal Revenue Code in the United States and comparable partnership allocation principles in other jurisdictions, which allocate profits and losses among partners. Internationally, the OECD BEPS project led by Pascal Saint-Amans Organisation for Economic Co-operation and Development tackles treaty abuse, transfer pricing and profit allocation issues that affect carry when value is created in multiple territories. The EU Anti-Tax Avoidance Directive produced by the Council of the European Union imposes anti-hybrid and interest limitation rules that can change outcomes for cross-border carried interest. These frameworks aim to align taxation with where economic activities and value creation occur rather than contractual form alone.

Domestic anti-avoidance and regulatory rules

Many countries apply controlled foreign corporation rules

Causes, consequences and local nuance

The legal complexity arises from the mobility of fund managers, the location of portfolio companies, and the variety of investor domiciles. Consequences of misalignment include double taxation, investor disputes, and reputational or compliance risk for funds operating across common law and civil law systems. Smaller markets or emerging economies may struggle to capture a fair share of tax on exits when managers are elsewhere, raising territorial equity concerns. Effective structuring therefore requires coordinated tax, legal, and regulatory planning with attention to partnership documentation, substance, treaty positions, and published guidance from the relevant institutions.